Zosano Pharma Corp Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Zosano Pharma Corp reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$18.61 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2019-08-14
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-06-30 was -$11.14M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-03-31 was -$7.47M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-06-30 was -$8.26M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$6.14M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for fiscal 2018 was -$29.12M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$26.84M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$25.69M.
- Zosano Pharma Corp net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$24.16M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2019-06-30 | -$11.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$18.61M 10-Q · filed 2019-08-14 | |||
| 2019-03-31 | -$7.47M 10-Q · filed 2019-05-14 | ||||
| 2018-12-31 | -$29.12M 10-K · filed 2019-03-25 | ||||
| 2018-06-30 | -$8.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$14.39M 10-Q · filed 2019-08-14 | -$20.28M derived: sum of 3 quarters · filed 2019-08-14 | -$27.11M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$6.14M 10-Q · filed 2019-05-14 | -$12.02M derived: sum of 2 quarters · filed 2019-05-14 | -$18.85M derived: sum of 3 quarters · filed 2019-05-14 | -$26.00M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$12.71M derived: sum of 2 quarters · filed 2019-03-25 | -$19.86M derived: sum of 3 quarters · filed 2019-03-25 | -$26.84M 10-K · filed 2019-03-25 | -$27.12M 10-K · filed 2018-03-12 |
| 2017-09-30 | -$6.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$13.98M derived: sum of 2 quarters · filed 2017-11-09 | -$20.95M 10-Q · filed 2017-11-09 | -$27.84M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2017-06-30 | -$7.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$14.13M 10-Q · filed 2017-08-10 | -$21.01M derived: sum of 3 quarters · filed 2018-05-15 | -$26.08M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2017-03-31 | -$6.98M 10-Q · filed 2018-05-15 | -$13.86M derived: sum of 2 quarters · filed 2018-05-15 | -$18.93M derived: sum of 3 quarters · filed 2018-05-15 | -$24.32M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$11.96M derived: sum of 2 quarters · filed 2018-03-12 | -$17.35M derived: sum of 3 quarters · filed 2018-03-12 | -$25.69M 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$5.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$10.46M derived: sum of 2 quarters · filed 2017-11-09 | -$18.80M 10-Q · filed 2017-11-09 | -$25.43M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | -$5.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$13.73M 10-Q · filed 2017-08-10 | -$20.36M derived: sum of 3 quarters · filed 2017-08-10 | -$26.92M derived: sum of 4 quarters · filed 2017-08-10 | |
| 2016-03-31 | -$8.34M 10-Q · filed 2017-05-09 | -$14.96M derived: sum of 2 quarters · filed 2017-05-09 | -$21.53M derived: sum of 3 quarters · filed 2017-05-09 | -$27.07M derived: sum of 4 quarters · filed 2017-05-09 | |
| 2015-12-31 | -$6.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$13.19M derived: sum of 2 quarters · filed 2017-03-01 | -$18.73M derived: sum of 3 quarters · filed 2017-03-01 | -$24.16M 10-K · filed 2017-03-01 | |
| 2015-09-30 | -$6.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$12.10M derived: sum of 2 quarters · filed 2016-11-09 | -$17.53M 10-Q · filed 2016-11-09 | -$19.44M derived: sum of 4 quarters · filed 2016-11-09 | |
| 2015-06-30 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$10.97M 10-Q · filed 2016-08-10 | -$12.88M derived: sum of 3 quarters · filed 2016-08-10 | -$15.96M derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | -$5.43M 10-Q · filed 2016-05-12 | -$7.34M derived: sum of 2 quarters · filed 2016-05-12 | -$10.42M derived: sum of 3 quarters · filed 2016-05-12 | -$13.97M derived: sum of 4 quarters · filed 2016-05-12 | |
| 2014-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$4.99M derived: sum of 2 quarters · filed 2016-03-29 | -$8.54M derived: sum of 3 quarters · filed 2016-03-29 | -$10.91M 10-K · filed 2016-03-29 | |
| 2014-09-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$6.63M derived: sum of 2 quarters · filed 2015-11-10 | -$9.00M 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$5.92M 10-Q · filed 2015-08-13 | |||
| 2014-03-31 | -$2.37M 10-Q · filed 2015-05-12 |